Comparison of Dexmedetomidine and Propofol in sedation efficacy in patients with elective upper gastrointestinal endoscopy
Phase 3
Recruiting
- Conditions
- pper gastrointestinal disorders.Encounter for screening for upper gastrointestinal disorderZ13.810
- Registration Number
- IRCT20190212042688N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients with elective upper gastrointestinal endoscopy
ASA class =3
Exclusion Criteria
Having cardiovascular disease (arrhythmia, AS, IHD, HTN, HF or EF <30%)
Having liver disease (Child-Pugh Classification C)
Having kidney disease (GFR <60%)
Having psychiatric illness (Major Depression, Mania, Psychosis)
SBP<90
Having Drug Addiction
Egg and soy allergy
Emergency endoscopy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedation. Timepoint: By monitoring, sedation will be recorded from the start of the drug administration (time 0) and every 5 minutes until the patient transferred to the recovery room. Method of measurement: Relaxation after taking drugs will asked using Ramsay Relaxation Scale from 0-5 (0-Restless,1-Relax,2-Sleepy,3-Confuse but Responded to Verbal Orders,4-No Response to Verbal orders,5-No Response to painful incitements) and will evaluated by an anesthesiologist.
- Secondary Outcome Measures
Name Time Method